Summary
Researchers sought to assess the incidence of and risk factors for cardiotoxicity related to anthracycline therapy in a racially and ethnically diverse cohort.
Source: Clinical Advisor
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
